Horowitz J, Sears M
Graefes Arch Clin Exp Ophthalmol. 1983;220(6):253-6. doi: 10.1007/BF00231351.
Effects of neurohypophyseal (NHP) and synthetic analogs on the pupil of the rabbit were explored. This was prompted by the recent emergence of synthetic analogs with selective agonist and antagonist properties. The miotic effect of the NHP was examined in an isolated iris preparation. Minimum concentrations of arginine-vasopressin (AVP) needed to cause threshold pupillary constriction were approximately 10(-10) M. The miotic potency of several NHP analogs correlated best with their pressor activity. In addition, the synthetic NHP pressor antagonist d(CH2)5 Tyr(Me)AVP specifically antagonized the miotic effect, confirming that a pressorlike receptor mediates this pharmacologic action of the NHP. We also employed the technique of in vivo intravitreal administration of pharmacologic doses of the NHP in the rabbit. Once again, potent miotic activity was demonstrated. The relative miotic potency of the NHP in vivo provided further support to the relationship between the NHP "pressor" receptor and pupillary constriction. We believe that the use of a variety of NHP natural and synthetic analogs may also prove helpful in investigating potential physiological effects of the NHP on other intraocular smooth muscle.
研究了神经垂体(NHP)及其合成类似物对兔瞳孔的作用。这是由近期具有选择性激动剂和拮抗剂特性的合成类似物的出现所引发的。在离体虹膜制备中检测了NHP的缩瞳作用。引起阈值瞳孔收缩所需的精氨酸加压素(AVP)的最低浓度约为10(-10)M。几种NHP类似物的缩瞳效力与其升压活性相关性最佳。此外,合成的NHP升压拮抗剂d(CH2)5 Tyr(Me)AVP特异性拮抗缩瞳作用,证实了一种类似升压的受体介导了NHP的这种药理作用。我们还采用了在兔体内玻璃体内注射药理剂量的NHP的技术。再次证明了强效的缩瞳活性。NHP在体内的相对缩瞳效力为NHP“升压”受体与瞳孔收缩之间的关系提供了进一步的支持。我们认为,使用多种NHP天然和合成类似物也可能有助于研究NHP对其他眼内平滑肌的潜在生理作用。